BR112018073155A2 - método para tratar doença autoimune e/ou inflamatória, e pacote de dieta - Google Patents

método para tratar doença autoimune e/ou inflamatória, e pacote de dieta

Info

Publication number
BR112018073155A2
BR112018073155A2 BR112018073155-2A BR112018073155A BR112018073155A2 BR 112018073155 A2 BR112018073155 A2 BR 112018073155A2 BR 112018073155 A BR112018073155 A BR 112018073155A BR 112018073155 A2 BR112018073155 A2 BR 112018073155A2
Authority
BR
Brazil
Prior art keywords
inflammatory disease
treating autoimmune
diet package
diet
autoimmune
Prior art date
Application number
BR112018073155-2A
Other languages
English (en)
Inventor
D. Longo Valter
Young Choi In
Original Assignee
University Of Southern California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Of Southern California filed Critical University Of Southern California
Publication of BR112018073155A2 publication Critical patent/BR112018073155A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pediatric Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

trata-se de um método para tratar doenças autoimunes e/ou inflamatórias que inclui uma etapa de identificar um indivíduo que tem uma doença autoimune/inflamatória gastrointestinal. uma dieta que imita jejum (fmd) é administrada ao indivíduo por um primeiro período de tempo.
BR112018073155-2A 2016-05-11 2017-05-11 método para tratar doença autoimune e/ou inflamatória, e pacote de dieta BR112018073155A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662334733P 2016-05-11 2016-05-11
US62/334,733 2016-05-11
PCT/US2017/032092 WO2017197076A1 (en) 2016-05-11 2017-05-11 Fasting mimicking diet (fmd) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.

Publications (1)

Publication Number Publication Date
BR112018073155A2 true BR112018073155A2 (pt) 2019-03-12

Family

ID=60267379

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018073155-2A BR112018073155A2 (pt) 2016-05-11 2017-05-11 método para tratar doença autoimune e/ou inflamatória, e pacote de dieta

Country Status (13)

Country Link
US (1) US11540550B2 (pt)
EP (1) EP3454867B1 (pt)
JP (1) JP2019515009A (pt)
KR (1) KR20180136551A (pt)
CN (1) CN109152790A (pt)
AU (1) AU2017261723B2 (pt)
BR (1) BR112018073155A2 (pt)
CA (1) CA3024272A1 (pt)
ES (1) ES2871060T3 (pt)
MX (1) MX2018013727A (pt)
RU (1) RU2749436C2 (pt)
WO (1) WO2017197076A1 (pt)
ZA (1) ZA201808272B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104880428B (zh) * 2015-06-23 2016-07-06 山西振东安特生物制药有限公司 一种胶体果胶铋或含胶体果胶铋制剂中铋含量的测定方法
CN104897668B (zh) * 2015-06-23 2016-08-24 山西振东安特生物制药有限公司 用于检测含胶体果胶铋制剂溶出度的方法
AU2017261723B2 (en) 2016-05-11 2023-02-09 University Of Southern California Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.
US11284640B2 (en) * 2017-02-14 2022-03-29 University Of Southern California Fasting mimicking diet
BR112020018564A2 (pt) 2018-03-15 2020-12-29 University Of Southern California Composição probiótica para doença gastrointestinal autoimune e/ou inflamatória, uso de uma dieta que simula jejum para prevenir ou tratar doença gastrointestinal autoimune e/ou inflamatória, e suplemento dietário
EP3876741A4 (en) * 2018-11-09 2022-08-31 L-Nutra NUTRIENT BAR FOR INTERMITTENT FASTING SIMULATE
US20220408780A1 (en) * 2020-02-11 2022-12-29 The E. Wolfson Medical Center A method effective for treating ulcerative colitis
TW202236983A (zh) * 2020-12-03 2022-10-01 南加州州立大學 提升骨骼肌再生及強度的模擬禁食生酮飲食(fmd)
US20220175007A1 (en) * 2020-12-09 2022-06-09 University Of Southern California Fasting mimicking ketogenic diet to improve immune function and vaccine response and minimize risk in adults and elderly
WO2023130071A1 (en) * 2021-12-31 2023-07-06 L-Nutra Inc. Fasting-mimicking diet
JP2024036813A (ja) * 2022-09-06 2024-03-18 太田油脂株式会社 機能性食品組成物及びその製造方法
CN117084401A (zh) * 2023-09-05 2023-11-21 浙江大学 Fmd方法在维持衰老肠道稳态方面的应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8302708D0 (en) 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
CN1889964B (zh) * 2003-12-12 2011-06-08 太阳化学株式会社 用于改善肠疾病的组合物
US20060235009A1 (en) 2005-02-08 2006-10-19 Richard Glickman Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
ES2891733T3 (es) 2007-03-28 2022-01-31 Univ Southern California Inducción de la resistencia diferencial al estrés y usos de la misma
US8865646B2 (en) 2007-03-28 2014-10-21 University Of South California Dietary compositions and methods for protection against chemotherapy, radiotherapy, oxidative stress, and aging
RU2392943C2 (ru) * 2007-11-22 2010-06-27 Людмила Александровна Орлова Способ разгрузочно-диетической терапии
JP2009263307A (ja) * 2008-04-28 2009-11-12 Taiyo Kagaku Co Ltd 炎症性腸疾患の予防・治療剤
RU2549954C2 (ru) 2009-10-22 2015-05-10 Юниверсити Оф Саутерн Калифорния Способы и диетологические составы для повышения эффективности и снижения побочных эффектов лечения рака
CA2798079A1 (en) 2010-04-28 2011-11-10 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
GB201011771D0 (en) 2010-07-13 2010-08-25 Bioinvent Int Ab Biological material and particular uses thereof
WO2012109353A2 (en) 2011-02-08 2012-08-16 University Of Southern California Growth hormone receptor deficiency causes a major reduction in pro-aging signaling, cancer and diabetes in humans
ES2821383T3 (es) * 2012-10-17 2021-04-26 Enterome Firmas genéticas de trastornos inflamatorios relacionados con el hígado y la enfermedad de Crohn
CA2888811C (en) 2012-10-22 2023-10-24 University Of Southern California A diet package, and uses thereof
MX2015010320A (es) * 2013-02-12 2016-06-02 Univ Southern California Metodos y dietas para proteger contra la quimiotoxicidad y enfermedades asociadas con la edad.
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
MX2016000102A (es) 2013-07-01 2016-08-18 Univ Southern California Condicion de ayuno como tratamiento dietetico de la diabetes.
WO2015107514A1 (en) * 2014-01-16 2015-07-23 The E. Wolfson Medical Center A composition and method effective for induction of remission of crohn's disease
US10172839B2 (en) 2014-03-06 2019-01-08 University Of Southern California Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues
US11406122B2 (en) 2014-04-02 2022-08-09 University Of Southern California Autoimmunity and multiple sclerosis treatment
EP4299061A3 (en) 2015-04-16 2024-02-28 University of Southern California Fasting mimicking diet (fmd) and glucose lowering drugs protect normal cells and generate cancer sensitizing conditions in response to standard and high glucose conditions induced by rapamycin and dexamethasone
MX2017014110A (es) 2015-05-06 2019-03-28 Univ Southern California Dieta que imita y mejora el ayuno para tratar la hipertensión y trastornos lipídicos.
CN105431005A (zh) 2015-11-19 2016-03-23 南车株洲电力机车研究所有限公司 一种换热装置
WO2017142952A1 (en) * 2016-02-15 2017-08-24 University Of Southern California Drug combinations and methods to stimulate embryonic-like regeneration to treat diabetes and other diseases
AU2017261723B2 (en) 2016-05-11 2023-02-09 University Of Southern California Fasting mimicking diet (FMD) as an immunoregulatory treatment for gastrointestinal autoimmune/inflammatory diseases.

Also Published As

Publication number Publication date
RU2018141550A (ru) 2020-06-11
MX2018013727A (es) 2019-08-29
AU2017261723B2 (en) 2023-02-09
WO2017197076A1 (en) 2017-11-16
EP3454867A1 (en) 2019-03-20
US11540550B2 (en) 2023-01-03
AU2017261723A1 (en) 2018-11-15
EP3454867B1 (en) 2021-03-24
JP2019515009A (ja) 2019-06-06
RU2018141550A3 (pt) 2020-09-03
EP3454867A4 (en) 2019-12-04
RU2749436C2 (ru) 2021-06-10
KR20180136551A (ko) 2018-12-24
CA3024272A1 (en) 2017-11-16
CN109152790A (zh) 2019-01-04
ZA201808272B (en) 2020-02-26
US20170325493A1 (en) 2017-11-16
ES2871060T3 (es) 2021-10-28

Similar Documents

Publication Publication Date Title
BR112018073155A2 (pt) método para tratar doença autoimune e/ou inflamatória, e pacote de dieta
BR112019011689A2 (pt) tratamento de uma doença do trato gastrointestinal com um inibidor de tnf
BR112018009251A2 (pt) aparelho cirúrgico e controlador principal personalizado para um aparelho cirúrgico
BR112017020893A2 (pt) método para o tratamento de câncer
BR112016023694A2 (pt) cartucho de prendedores compreendendo cavidades de prendedor que incluem recursos para o controle dos prendedores
UY37594A (es) Biomarcador inmunologico para predecir el efecto clinico de inmunoterapia del cancer
BR112017003163A2 (pt) dispositivo de infraestrutura modular, sistema de infraestrutura e processo para operação de um dispositivo de infraestrutura
BR112016007121A2 (pt) método para a análise de acústica de uma máquina, sistema para a análise de acústica de uma máquina e produto
BR112017024555A2 (pt) moduladores de ccr2
BR112016025470A2 (pt) ?hdl terapêutico?
BR112017003472A2 (pt) anticorpos, fragmento fab de anticorpo e método para o tratamento de uma doença inflamatória
CL2018000597A1 (es) Métodos para tratar enfermedades inflamatorias
BR112017014419A2 (pt) diagnose e tratamento de diabetes incipiente
BR112017016229A2 (pt) sistema e método para operação de um sistema de ressonância magnética para capturar dados de ressonância magnética de um fantasma dentro de uma zona de medição; e produto de programa de computador
EA201790475A1 (ru) Способы лечения системной красной волчанки с использованием доменного антитела против cd28
BR112017007860A2 (pt) método para tratar uma doença de gordura no fígado
BR112019003785A2 (pt) tabaco resistente a vírus e método de melhoramento para o mesmo
BR112017004299A2 (pt) dispositivo e método de processamento de informação, e, programa.
BR112017001971A2 (pt) ?métodos e composições para diagnosticar e tratar distúrbios inflamatórios intestinais?
BR112019004913A2 (pt) vacinas que compreendem polipeptídeos de mycobacterium leprae para a prevenção, tratamento e diagnóstico de lepra
BR112016018024A2 (pt) Reconhecimento de cena ao vivo que permite modificação de imagem dependente de cena antes de gravação ou exibição de imagem
CY1124881T1 (el) Στρωματωση γονοτυπου στην θεραπεια και προληψη του διαβητη
BR112018012909A2 (pt) freio a disco
BR112018076703A2 (pt) compostos úteis para tratar distúrbios metabólicos
BR112017027304A2 (pt) método para o diagnóstico de doença de farber

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2591 DE 01/09/2020 POR TER SIDO INDEVIDA.

B06W Patent application suspended after preliminary examination (for patents with searches from other patent authorities) chapter 6.23 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2722 DE 07-03-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.